JD.com, Inc. (NASDAQ: JD) Q3 2020 earnings call dated Nov. 16, 2020
Corporate Participants:
Ruiyu Li — Senior Director of Investor Relations
Sandy Ran Xu — Chief Financial Officer
Lei Xu — Chief Executive Officer, JD Retail
Analysts:
Ronald Keung — Goldman Sachs — Analyst
Thomas Chong — Jefferies Hong Kong — Analyst
Jin K. Yoon — New Street Research — Analyst
Gregory Zhao — Barclays — Analyst
Eddie Leung — Bank of America Merrill Lynch — Analyst
Alicia Yap — Citi Research — Analyst
Jerry Liu — UBS — Analyst
James Lee — Mizuho — Analyst
Jialong Shi — Nomura — Analyst
Eddy Wang — Morgan Stanley — Analyst
Han Joon Kim — Macquarie Group — Analyst
______
To read the full earnings call transcript, click here.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on